Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Liposomal Bupivacaine Versus Conventional Bupivacaine for Pain Control in Patients Undergoing Laparoscopic Radical Nephrectomy: A Pilot Randomized Trial

NCT06231355 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06231355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06231355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Liposomal Bupivacaine Versus Conventional Bupivacaine for Pain Control in Patients Undergoing Laparoscopic Radical Nephrectomy: A Pilot Randomized Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 21, 2024
Completion date
October 14, 2024
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, local anesthetics, paravertebral block, regional block